10x Genomics Inc’s recent filing unveils that its Chief Executive Officer Saxonov Serge unloaded Company’s shares for reported $91612.0 on Nov 22 ’24. In the deal valued at $13.69 per share,6,693 shares were sold. As a result of this transaction, Saxonov Serge now holds 872,574 shares worth roughly $14.09 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Hindson Benjamin J. sold 5,807 shares, generating $79,485 in total proceeds. Upon selling the shares at $13.69, the insider now owns 339,897 shares.
Before that, Hindson Benjamin J. bought 5,734 shares. 10x Genomics Inc shares valued at $76,377 were divested by the Officer at a price of $13.32 per share.
Leerink Partners initiated its 10x Genomics Inc [TXG] rating to an Outperform in a research note published on September 03, 2024; the price target was $35. A number of analysts have revised their coverage, including Jefferies’s analysts, who increased its forecast for the stock in late July from “a Hold” to “a Buy”. JP Morgan also remained covering TXG and has decreased its forecast on July 18, 2024 with a “Neutral” recommendation from previously “an Overweight” rating. Deutsche Bank revised its rating on July 10, 2024. It rated TXG as “a Hold” which previously was an “a Buy”.
Price Performance Review of TXG
On Tuesday, 10x Genomics Inc [NASDAQ:TXG] saw its stock unchanged to $16.15. Over the last five days, the stock has gained 2.09%. 10x Genomics Inc shares have fallen nearly -71.14% since the year began. Nevertheless, the stocks have fallen -66.93% over the past one year. While a 52-week high of $57.90 was reached on 01/02/24, a 52-week low of $12.95 was recorded on 11/19/24. SMA at 50 days reached $16.13, while 200 days put it at $23.50.
Levels Of Support And Resistance For TXG Stock
The 24-hour chart illustrates a support level at 15.68, which if violated will result in even more drops to 15.22. On the upside, there is a resistance level at 16.67. A further resistance level may holdings at 17.20. The Relative Strength Index (RSI) on the 14-day chart is 53.97, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.75, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 15.47%. Stochastics %K at 85.15% indicates the stock is a selling.
How much short interest is there in 10x Genomics Inc?
A steep rise in short interest was recorded in 10x Genomics Inc stocks on 2024-11-29, dropping by -0.7 million shares to a total of 6.9 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-31 was 7.61 million shares. There was a decline of -10.19%, which implies that there is a negative sentiment for the stock.
